Li Lu-Yuan, Barlow Keith D, Metheny-Barlow Linda J
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15210, USA.
Pediatr Endocrinol Rev. 2005 Mar;2(3):399-408.
The angiopoietins are a class of growth factors that activate the Tie2 receptor and play important roles in the regulation of angiogenesis. Proper regulation of angiogenesis is required for both embryonic vascular development and physiological processes in the adult such as wound healing and the female reproductive cycle, while aberrant regulation of angiogenesis contributes to a number of pathological conditions. As a result, an increasing amount of attention has been directed toward analysis of the expression and function of the angiopoietins and Tie2. Mounting evidence suggests that not only does altered expression of these molecules play a pivotal role in processes requiring vessel growth and remodeling, but has been implicated in a variety of other biological and pathological processes as well. These data suggest that modulation of the Ang/Tie2 system may prove to be a desirable therapeutic goal in the treatment of a diverse array of pathological conditions.
血管生成素是一类生长因子,可激活Tie2受体,并在血管生成的调节中发挥重要作用。胚胎血管发育以及成人生理过程(如伤口愈合和女性生殖周期)都需要对血管生成进行适当调节,而血管生成的异常调节会导致多种病理状况。因此,越来越多的注意力被导向血管生成素和Tie2的表达及功能分析。越来越多的证据表明,这些分子的表达改变不仅在需要血管生长和重塑的过程中起关键作用,还与多种其他生物学和病理过程有关。这些数据表明,调节血管生成素/Tie2系统可能被证明是治疗多种病理状况的理想治疗目标。